Indonesia vs Lesotho: HIV/AIDS deaths averted by antiretroviral therapy
Indonesia
14,389 deaths
in 2024
Lesotho
16,464 deaths
in 2024
Indonesia rank
17th
Lesotho rank
15th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Indonesia
- Lesotho
How they compare
Lesotho currently reports 16,464 deaths against 14,389 deaths in Indonesia, a difference of 2,075 deaths.
That makes Lesotho's figure about 1.1 times Indonesia's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Lesotho ahead.
Indonesia ranks 17th and Lesotho ranks 15th of 157 countries.
Lesotho has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Indonesia | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 1990s | -0.0142 deaths | 0 deaths | 0.0142 deaths | Lesotho |
| 2000s | 655.3 deaths | 3,511 deaths | 2,856 deaths | Lesotho |
| 2010s | 6,279 deaths | 15,323 deaths | 9,044 deaths | Lesotho |
| 2020s | 12,043 deaths | 17,301 deaths | 5,258 deaths | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Indonesia or Lesotho?
- Lesotho, at 16,464 deaths against 14,389 deaths in Indonesia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Indonesia and Lesotho?
- 2,075 deaths, with Lesotho ahead.
- How many years of comparable data are there for Indonesia and Lesotho?
- 35 years are reported by both, from 1990 to 2024.
- How do Indonesia and Lesotho rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Indonesia ranks 17th and Lesotho ranks 15th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.